SEC Form 4 · accession 0001209191-18-062820
BIOLASE, INC · BIOL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Todd Norbe
Officer — President and CEO · Director
Period of report
Dec 12, 2018
Accepted (ET)
Dec 14, 2018 · 7:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 12, 2018 | P | 5,000 | $1.03 | A | 5,000 | D | |
| Common Stock | Dec 13, 2018 | P | 4,100 | $1.04 | A | 9,100 | D | |
| Common Stock | Dec 13, 2018 | P | 3,700 | $1.03 | A | 12,800 | D | |
| Common Stock | Dec 13, 2018 | P | 2,200 | $1.02 | A | 15,000 | D |
Table II — derivative securities
No Table II lines on this filing.